164 related articles for article (PubMed ID: 30608432)
1. Serum angiopoietin-2 concentrations of post-PCI are correlated with the parameters of renal function in patients with coronary artery disease.
Jian W; Li L; Wei XM; Guan JH; Yang GL; Gui C
Medicine (Baltimore); 2019 Jan; 98(1):e13960. PubMed ID: 30608432
[TBL] [Abstract][Full Text] [Related]
2. Effects of Percutaneous Coronary Intervention on Serum Angiopoietin-2 in Patients with Coronary Heart Disease.
Zeng ZY; Gui C; Li L; Wei XM
Chin Med J (Engl); 2016 Mar; 129(6):631-5. PubMed ID: 26960364
[TBL] [Abstract][Full Text] [Related]
3. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.
Azzalini L; Laricchia A; Regazzoli D; Mitomo S; Hachinohe D; Bellini B; Demir OM; Poletti E; Maccagni D; Colombo A
J Invasive Cardiol; 2019 Jun; 31(6):176-182. PubMed ID: 30865912
[TBL] [Abstract][Full Text] [Related]
4. Renal function after percutaneous coronary interventions depending on the type of hydration.
Jarocka IT; Bachórzewska-Gajewska H; Kobus G; Czaban S; Małyszko J; Dobrzycki S
Adv Med Sci; 2013; 58(2):369-75. PubMed ID: 24285128
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
[TBL] [Abstract][Full Text] [Related]
6. Circulating Angiopoietin-2 and Its Soluble Receptor Tie-2 Concentrations Are Related to Renal Function in Two Population-Based Cohorts.
Hennings A; Hannemann A; Rettig R; Dörr M; Nauck M; Völzke H; Lerch MM; Lieb W; Friedrich N
PLoS One; 2016; 11(11):e0166492. PubMed ID: 27893762
[TBL] [Abstract][Full Text] [Related]
7. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW
J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952
[TBL] [Abstract][Full Text] [Related]
8. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?
Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Pawlak K; Mysliwiec M; Lawnicki S; Szmitkowski M; Dobrzycki S
Kidney Blood Press Res; 2007; 30(6):408-15. PubMed ID: 17901710
[TBL] [Abstract][Full Text] [Related]
9. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
Nawa T; Nishigaki K; Kinomura Y; Tanaka T; Yamada Y; Kawasaki M; Minatoguchi S
Int J Cardiol; 2015 Sep; 195():228-34. PubMed ID: 26048382
[TBL] [Abstract][Full Text] [Related]
10. Ultra-Low Contrast Volume for Patients with Advanced Chronic Kidney Disease Undergoing Coronary Procedures.
Rozenbaum Z; Benchetrit S; Rozenbaum E; Neumark E; Mosseri M; Pereg D
Nephron; 2018; 138(4):296-302. PubMed ID: 29393219
[TBL] [Abstract][Full Text] [Related]
11. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
[TBL] [Abstract][Full Text] [Related]
12. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
Shehata M; Hamza M
Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
[TBL] [Abstract][Full Text] [Related]
13. Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease.
Deguchi Y; Saito Y; Nakao M; Shiraishi H; Sakamoto N; Kobayashi S; Kobayashi Y
Heart Vessels; 2021 Mar; 36(3):315-320. PubMed ID: 32930865
[TBL] [Abstract][Full Text] [Related]
14. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
[TBL] [Abstract][Full Text] [Related]
15. Effects of two different treatments with continuous renal replacement therapy in patients with chronic renal dysfunction submitted to coronary invasive procedures.
Spini V; Cecchi E; Chiostri M; Landi D; Romano SM; Mattesini A; Gensini GF; Giglioli C
J Invasive Cardiol; 2013 Feb; 25(2):80-4. PubMed ID: 23388226
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin - Potential biomarker of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventions.
Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Koc-Zorawska E; Matuszkiewicz-Rowinska J; Dobrzycki S
Adv Med Sci; 2019 Sep; 64(2):211-215. PubMed ID: 30818219
[TBL] [Abstract][Full Text] [Related]
17. Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Jian W; Guan JH; Zheng WB; Mo CH; Xu YT; Huang QL; Wei CM; Wang C; Yang ZJ; Yang GL; Gui C
Aging (Albany NY); 2020 Mar; 12(6):5140-5151. PubMed ID: 32182213
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N-terminal pro-brain natriuretic peptide.
Jian W; Mo CH; Yang GL; Li L; Gui C
J Clin Lab Anal; 2019 Oct; 33(8):e22972. PubMed ID: 31257664
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI.
Jian W; Li L; Wei XM; Wu CQ; Gui C
Medicine (Baltimore); 2019 Feb; 98(5):e14216. PubMed ID: 30702576
[TBL] [Abstract][Full Text] [Related]
20. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
